What Is (or Isn’t) a Public Health “Emergency”?

By Rebecca Haffajee

In this week’s issue of New England Journal of Medicine, Michelle Mello, Wendy Parmet, and I write about what constitutes — or should constitute — a “public health emergency”. The law provides for emergency declarations, which suspend ordinary legal standards and processes in order to avoid catastrophe, on many levels (international, federal, state, local) and in public health or more general contexts. We focus our discussion at the state level, using Governor Deval Patrick’s declaration of the opioid-addiction crisis as a public health emergency as an opportunity to explore the appropriate parameters of these powers. My co-authors and I don’t debate the public health significance of opioid addiction in the Commonwealth, nor the specific measures ordered pursuant to this declaration. We do question the expanding use of public health emergency powers beyond the traditional arenas of infectious disease outbreaks, natural disasters, and acts of bioterrorism into new territories, such as injuries and chronic disease.

State laws provide governors and their top health officers with considerable latitude in declaring public health emergencies. But the powers available upon such declarations are extraordinary and should be wielded with care. My co-authors and I identify three key criteria that seem to be enshrined in the spirit of public health emergency laws: “the situation is exigent, the anticipated or potential harm is calamitous, and the harm cannot be avoided through ordinary procedures.” In the absence of these criteria, the invocation of such emergencies may raise heightened concerns — for instance, if ensuing orders involve serious infringements on individual and private business rights — and could result in a loss of public trust in health officials and legitimacy in public health laws. We caution against setting such troubling precedent.

Read more in our Perspective, entitled “What Is a Public Health “Emergency”?“.

haffajee

Rebecca Haffajee is a Thomas O. Pyle Fellow in Pharmaceutical Policy Research in the Department of Population Medicine at the Harvard Pilgrim Healthcare Institute. After completing her JD and MPH at Harvard in 2006, Rebecca practiced as a health care lawyer for several years. She entered the Harvard PhD Program in Health Policy in 2010 with a concentration in Evaluative Science and Statistics. Her dissertation research is focused on the empirical effects of laws and policies on health outcomes, with particular emphases on public health laws and patient safety/quality initiatives. She is currently working on a longitudinal assessment of the impact of mental health parity laws on mental health treatment and outcomes. Rebecca was a Student Fellow at the Petrie-Flom Center in 2010 - 2011. Her research paper was: "Probing the Constitutional Basis for Distracted Driving Laws: Do they Actually Reduce Fatalities?"

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.